Vitamin C may impact efficacy of certain cancer drugs, journal says

PHILADELPHIA Vitamin C may interfere with the efficacy of several cancer drugs in mice, the journal Cancer Research reported Wednesday, including doxorubicin, cisplatin, vincristine, methotrexate and imatinib.

“These results support the hypothesis that vitamin C supplementation during cancer treatment may detrimentally affect therapeutic response,” the authors concluded.